Lawyers

Stephan Rauch is an associate in the Frankfurt office’s General Practice group. He focuses primarily on the representation of European and U.S. clients in equity capital markets transactions and in a wide range of international public and private M&A transactions. He also advises on general corporate matters, such as shareholder meetings, transformational transactions and post-transaction corporate measures.

Dr. Rauch joined S&C in 2017 and is admitted to the Frankfurt bar.

SELECTED REPRESENTATIONS

• 468 SPAC I on (i) its €300 million private placement and listing on the Frankfurt Stock Exchange and (ii) its business combination agreement with Boxine GmbH, valuing the combined company tonies SE at a pro forma equity value of €990 million
• 468 SPAC II on its €210 million private placement and listing on the Frankfurt Stock Exchange
• Axioma in its acquisition by Deutsche Börse for $850 million cash and debt free
• Bayer in its definitive agreement with Elanco Animal Health for Elanco to acquire Bayer’s Animal Health business in a transaction valued at $7.6 billion
• Lakestar SPAC I on (i) its €275 million private placement and listing on the Frankfurt Stock Exchange and (ii) its €1.2 billion (equity value) merger with HomeToGo, the first German De-SPAC deal of its kind
• Porsche Automobil Holding (Porsche SE) on the €10.1 billion acquisition of 25% of the ordinary voting shares of Porsche AG from Volkswagen AG (concurrent with the Porsche IPO)
• Praxair on (i) the $80 billion merger of equals with Linde, (ii) the €2.8 billion squeeze-out of the minority shareholders of Linde following the merger and (iii) the representation of Linde in the appraisal proceedings following the squeeze-out
• Rocket Internet on its delisting by way of a public self-tender delisting offer